3,4-Difluoroamphetamine

Chemical compound related to amphetamines

3,4-Difluoroamphetamine (DFA) is a chemical compound belonging to the amphetamine class. It is structurally similar to other amphetamines, with the addition of two fluorine atoms at the 3 and 4 positions of the phenyl ring.

Chemical structure

Chemical structure of 3,4-Difluoroamphetamine

The chemical structure of 3,4-Difluoroamphetamine is characterized by the presence of a phenethylamine core, with a methyl group attached to the alpha carbon, and two fluorine atoms substituted at the 3 and 4 positions of the aromatic ring. This modification distinguishes it from other amphetamines, such as amphetamine and methamphetamine.

Pharmacology

3,4-Difluoroamphetamine acts as a central nervous system stimulant. It is believed to exert its effects by increasing the release of neurotransmitters such as dopamine, norepinephrine, and serotonin in the brain. The presence of fluorine atoms may alter its pharmacokinetic properties compared to non-fluorinated amphetamines.

Synthesis

The synthesis of 3,4-Difluoroamphetamine involves the introduction of fluorine atoms into the phenyl ring of the amphetamine structure. This can be achieved through various chemical reactions, including electrophilic aromatic substitution using fluorinating agents.

Legal status

The legal status of 3,4-Difluoroamphetamine varies by country. In many jurisdictions, it is considered a controlled substance due to its structural similarity to other regulated amphetamines. It is important to consult local regulations to determine its legal classification.

Potential uses

While 3,4-Difluoroamphetamine is primarily of interest in research settings, its potential applications include studies on neurotransmitter systems and the development of new pharmacological agents. However, its use in humans is not well-documented, and it is not approved for medical use.

Safety and toxicity

The safety profile of 3,4-Difluoroamphetamine is not well-established. As with other amphetamines, potential risks include cardiovascular effects, neurotoxicity, and addiction. Further research is needed to fully understand its toxicological properties.

Related pages

• Amphetamine
• Fluoroamphetamine
• Central nervous system stimulant
• Neurotransmitter

3,4-Difluoroamphetamine

• 
  Structure of 3,4-Difluoroamphetamine